
|Articles|April 24, 2006
Accredo wins Flolan agreement
Accredo Health Group, a subsidiary of Medco, won a five-yearcontract as the sole specialty pharmacy for Flolan (epoprostenolsodium, Myogen) for pulmonary arterial hypertension (PAH). Terms ofthe deal were not announced.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement































